Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

GeoVax Labs (GOVX) Debt to Equity (2016 - 2021)

GeoVax Labs (GOVX) has disclosed Debt to Equity for 11 consecutive years, with $0.0 as the latest value for Q1 2021.

  • On a quarterly basis, Debt to Equity rose 104.43% to $0.0 in Q1 2021 year-over-year; TTM through Mar 2021 was $0.0, a 104.43% increase, with the full-year FY2020 number at $0.0, up 108.9% from a year prior.
  • Debt to Equity was $0.0 for Q1 2021 at GeoVax Labs, down from $0.0 in the prior quarter.
  • In the past five years, Debt to Equity ranged from a high of $0.0 in Q3 2020 to a low of -$0.38 in Q1 2018.
  • A 4-year average of -$0.07 and a median of -$0.03 in 2019 define the central range for Debt to Equity.
  • Biggest YoY gain for Debt to Equity was 108.9% in 2020; the steepest drop was 917.53% in 2020.
  • GeoVax Labs' Debt to Equity stood at -$0.04 in 2018, then surged by 55.31% to -$0.02 in 2019, then surged by 108.9% to $0.0 in 2020, then plummeted by 61.78% to $0.0 in 2021.
  • Per Business Quant, the three most recent readings for GOVX's Debt to Equity are $0.0 (Q1 2021), $0.0 (Q4 2020), and $0.0 (Q3 2020).